High ITGB4 expression is a prognostic factor in CRC and is associated with drug resistance mechanisms in breast cancer, such as resistance to tamoxifen-induced apoptosis via the PI3K/Akt pathway and anoikis resistance through RAC1 signaling [95, 96]. Here, ITGB4 is linked to breast cancer.